Chondrosarcoma yielded gelatinous material on aspiration and was diagnosed cytologically in all six patients after correlation with the clinical and radiological information. Five cases were of low grade and one case was of high-grade malignancy. The low-grade chondrosarcomas showed mildly atypical chondroid cells situated in lacunae with an abundant chondromyxoid matrix. Dissociated single cells were relatively fewer in number. Mitotic figures were less frequently encountered. The high-grade tumors in contrast showed predominantly dissociated cells in a less abundant matrix. Cells were round to polygonal, with a variable amount of dense often vacuolated cytoplasm. Binucleate and multinucleate cells as well as mitotic figures were more frequent.
MFH smears (Fig. 1c and d) consisted mainly of a mixed population of spindle cells, histiocytoid, and pleomorphic cells. Varying amounts of multinucleated giant cells of the osteoclast type, as well as foamy cells and chronic inflammatory cells were observed. The nuclei of the tumor cells were quite atypical, especially these of the malignant giant cells. Typical and atypical mitoses were present.
The smears of Ewing sarcoma (Fig. 2) were cellular and showed malignant small round cells dispersed singly as well as arranged in loose clusters with frequent rosettes. The cells had scanty cytoplasm and round nuclei with fine granular chromatin and inconspicuous nucleoli. Five cases showed a positive reaction to CD99 and a negative reaction to LCA and desmin, confirming the diagnosis of Ewing sarcoma. A therapeutic decision was taken on the bases of FNAC only and neoadjuvant chemotherapy was started immediately without histopathological confirmation.
The smears from the three cases of plasma cell myeloma (Fig. 3) were composed of numerous plasma cells with varying degrees of maturation. Binucleate and multinucleate forms were frequently observed. All the cases showed an M band on serum electrophoresis. Chemotherapy started on the basis of FNAC diagnosis only. There was no need for biopsy for confirmation in these cases.
A case of chordoma (Fig. 4) was diagnosed in a 50-year-old man with a sacral tumor. Smears showed numerous large cells with pale-stained vacuolated cells and ovoid nuclei (physaliferous cells). Cells showed well-defined cytoplasmic borders, and the nuclei had evenly distributed chromatin with prominent nucleoli. Some smaller uniform tumor cells were also present.
Metastatic bone tumors
Fifteen cases (30.6%) proved to be metastatic neoplasms (Table 4 and Fig. 5). Nine cases (60%) had relevant radiological and clinical findings and the diagnosis was confirmed with IHC study. Surgical follow-up was available for the case mistyped as chondrosarcoma by FNAC. The most frequently aspirated sites showing metastatic bone tumor were the vertebral and pelvic bones. The most frequent type of metastatic carcinoma was adenocarcinoma (10 cases). In nine cases, the primary site was confirmed by an IHC panel. Three cases were positive for GCDFP-15, supporting a breast primary site of origin. Two cases showed a positive reaction for Cdx-2 and a negative reaction for GCDFP-15, supporting the colonic origin of tumor cells. In two cases, the tumor cells stained positively with TTF-1 and showed no IHC reaction for GCDFP-15 and Cdx-2, supporting pulmonary adenocarcinoma as primary. Two cases showed positivity to PSA. The remaining five cases that were not subjected to IHC because of deficient cytologic material, morphology together with the available history, confirmed the diagnosis of metastasis (two cases of squamous cell carcinoma of laryngeal and bladder origin, two cases of primary soft tissue sarcoma, and one case of malignant melanoma).
Suspicious and inadequate cases
We recommended histopathologic examination for all our suspicious and inadequate cases (13 cases, 15.3%). Subsequent histopathologic examination of the nine suspicious cases had confirmed their malignant nature (three metastatic carcinomas, four sarcomas, and two non-Hodgkin’s lymphoma). Core biopsies were performed for the four inadequate cases; their histopathologic examination confirmed two of them as malignant (osteosarcoma and Ewing sarcoma). The other two cases included one ‘giant cell tumor’ case and one ‘aneurysmal bone cyst’ case.
Benign, low-grade tumors, and inflammatory lesions
Twenty-three (27.1%) cases were benign or low-grade tumors (Table 1). A giant cell tumor was the most frequently identified lesion. The smears showed abundant round to oval polygonal or elongated mononuclear cells evenly mixed with numerous osteoclasts-like giant cells that may be very large and contain 50 to 100 nuclei. Radiographic findings (epiphyseal lytic lesion of long bones without perilesional sclerosis) and clinical characteristics (young adults) allowed for a definitive diagnosis in all five cases.
The smears from Langerhans cell histiocytosis cases were composed of Langerhans cells with its characteristic reniform nuclei with irregular notches and grooves. The Langerhans cells were frequently admixed with large number of eosinophils, as well as lymphocytes, neutrophils and plasma cells. Multinucleated osteoclast-like giant cells and occasionally lipid laden histiocytes were also seen. CD1a confirmed the diagnosis in three of the cases.
Three cases of aneurysmal bone cysts yielded rather low cellularity and considerable amount of blood. Spindle cell clusters and osteoclastic giant cells were observed along with hemosiderin-laden macrophages and osteoblasts. Radiologic features played a major role in arriving at the diagnosis.
The remaining benign cases were reported as negative for malignant cells with a comment statement describing the subcategory or subclassification of the lesion and the most likely differential diagnosis. The benign lipomatous lesions included classic lipoma, fibrolipoma, and angiolipoma. The inflammatory lesions included acute and chronic inflammation, abscess, and granulomatous inflammation.
The diagnosis of bone lesions can be made in a variety of ways, including FNAC, core biopsy, or open biopsy. Each of these diagnostic tools has advantages and disadvantages. When compared with open biopsy, FNAC is a simple, outpatient procedure that is well tolerated by patients and has a minimal risk of complications. When the material is sufficient, it is usually possible to separate benign from malignant lesions as well as to subtype malignancies. Differentiation between a primary and metastatic lesion can also be made using this method (Kabukçuoglu et al., 1998). In addition, the multiple direction of the FNAC needle enables sampling of different parts of large tumors, as opposed to a single small core biopsy or open biopsy. However, FNAC can have sampling errors attributable to low cellularity, inadequate sampling of the target, and copious cystic/bloody/necrotic material (Nagira et al., 2002). Despite these difficulties, FNAC is being used as a diagnostic modality for initial diagnoses, as well as for recurrences and metastases of bone lesions in numerous medical centers (Bommer et al., 1997; Söderlund et al., 2004; Handa et al., 2005; Mehrotra et al., 2007; Layfield, 2009). Treatment with radiation and/or chemotherapy can be initiated without any delay, as the aspiration wound is not endangered. In addition, using FNAC as the diagnostic method, the possibilities for salvage of a limb improve, because there is less disruption of soft tissue and less distortion of the affected bone (Jorda et al., 2000).
FNAC is considered an important procedure in the diagnosis of bone lesions because of its high accuracy. An accuracy rate of 91% was achieved in this study, but rates as high as 95% have been reported (Bommer et al., 1997; Jorda et al., 2000; Mehrotra et al., 2007). Adequacy of the aspirate plays an important role in achieving this rate, which in turn depends on the site, characteristics, histologic grade of the tumor, and adequacy of the clinical and radiologic data (Wahane et al., 2007).
As many malignant primary bone tumors have palpable soft tissue extensions, which can be easily aspirated, we used size 23 G needles for most of the aspirates. Needles of shorter lengths only hit the reactive zone and may lead to false-negative results. In the deeply seated lesions, the use of image guidance can help to localize the lesion appropriately. The material obtained was fixed immediately in 95% ethyl alcohol and stained using the modified Papanicolaou method. This has the advantage of better nuclear detail and ease of comparison with histological sections. Whenever sufficient material is available, cell block preparations can be processed and immunocytochemistry can be applied; this helps to resolve morphologic deadlocks.
As reported elsewhere (Nnodu et al., 2006; Eyre et al., 2009; Layfield, 2009), osteosarcoma was the most frequent primary malignant tumor. The clinical features of age at presentation, rapid onset, radiographof an irregularly outlined osseous defect with cortical destruction, sun-burst appearance, and Codman’s triangle with the characteristic cytological features mentioned previously (Fig. 1a and b) were mandatory and enough for establishing the diagnosis. All cases of osteosarcoma (n=10) were diagnosed by these collaborative studies and were confirmed by histopathology after excision of the tumors. In one case, the morphologic features were diagnostic of malignancy; however, typing as osteosarcoma was not conclusive because of the absence of osteoid.
It was difficult to distinguish our two cases of the chondroblastic variant of osteosarcoma from high-grade chondrosarcoma. This distinction was possible only as patients were young (12 and 16 years old) together with metaphyseal involvement of the affected bones and relatively more nuclear hyperchromasia and pleomorphism.
The second most frequent primary malignant bone tumor in our study was Ewing sarcoma (eight of 34 cases), constituting 23.5% of the primary malignant cases. The reported incidence in the literature varies widely from 6% (Chow et al., 2011) to 39% (Eyre et al., 2009). This may depend on differences in the age groups involved in each study. The predilection for the teenage group, together with the characteristic radiographic findings of a permeative diaphyseal process associated with an aggressive ‘onion-skin’ type of periostitis, suggests the diagnosis of Ewing sarcoma. Unfortunately, cytomorphologic features cannot differentiate Ewing sarcoma from other blue round cell tumors of childhood (lymphoma mainly). Accordingly, more studies were needed for confirmation (immunocytochemistry on cell blocks, or tissue biopsy and IHC). The cytologic diagnosis of Ewing sarcoma was confirmed by an immunocytochemical panel in 62.5% of cases (positive reaction to CD99 and negative reaction to LCA). In the remaining 37.5% of cases, tissue biopsy and IHC confirmed the diagnosis.
In the current study, cases of chondrosarcoma constituted 17.6% of all primary tumors. This is comparable to 20% reported by Flemming and Murphey (2000). All the six cytologically diagnosed cases of chondrosarcoma were confirmed histopathologically. One case was diagnosed cytologically as chondrosarcoma and was proved to be metastatic lobular carcinoma by histopathology. This case lacked adequate clinical data including a history of primary breast cancer and also the radiological findings of the bony lesion were insufficient. This deficient clinicoradiologic correlation together with the subtle morphologic features of tumor cells that present as separate round and oval cells with mild atypical nuclear features and focal cytoplasmic vacuolations resulted in false cytologic typing of this case as chondrosarcoma.
Plasma cell myeloma as an entity was found in 8.8% of our studied cases of primary bone tumors. This result is in agreement with 8.3% observed by Shah et al (1999). Cytological smears of all three cases showed typical plasma cells so that a correct diagnosis could be made in all of the cases. Serum electrophoresis was useful in confirming the diagnosis.
Excellent cytologic details obtained by FNAC in MFH and the accuracy of the results make FNAC a highly reliable procedure in the diagnosis of this tumor (Tarkkanen et al., 2006). Chordomas (Walaas and Kindblom, 1991; Bommer et al., 1997) and NHL (Chao et al., 2001) can also be diagnosed easily using this diagnostic technique.
Metastatic tumors accounted for 17.6% (15 of 85 cases) of bone lesions in this study, which is less than the figures reported in the literature: 44 and 28.1% (Jorda et al., 2000; Nnodu et al., 2006). This could be explained by the fact that in our institute, radiology alone is considered sufficient for the diagnosis of metastatic tumors in bone in patients with a history of primary tumor elsewhere. Previous studies have adequately reported the high diagnostic accuracy of FNAC of bone in the diagnosis of metastatic lesions (James and Frable, 1983; Jorda et al., 2000). In our series, 93.3% (14 of 15 cases) of metastatic bone tumor were diagnosed correctly by FNAC. The presence of a clinical history of malignancy and the familiarity with the previous morphology of the known malignancy enhance the ability of the FNA to make a more definitive diagnosis, which may explain why 14 of the 49 malignancies were successfully subclassified as a metastatic carcinoma. An appropriate diagnosis of a metastatic lesion by FNAC facilitates either nonoperative management or contemporary surgical reconstructive techniques.
Benign and borderline bony lesions constituted 23 of 85 cases of our study, with a frequency of 27%. This result is somewhat lower than the 38% reported by Moatasim and Haque (2005). Giant cell tumor of bone and inflammatory bony lesions constituted the majority of these cases, with a frequency of 21.7% each. The frequency of cases of giant cell tumor in this study was slightly lower than the 28% reported in the literature (Eyesan et al., 2011). This may be attributed to the relatively larger number of cases in our study.
The characteristic radiological picture of giant cell tumor plays a crucial role in the diagnosis of this borderline tumor. This tumor presents as a lytic lesion centered in the epiphysis but involving the metaphysis and extending at least in part to the adjacent articular cortex. Most are eccentric, but become symmetric and centrally located with growth. Most cases show circumscribed borders or so-called geographical destruction with no periosteal reaction unless a pathological fracture is present. There is no mineralized tumor matrix (Purohit and Pardiwala, 2007). This characteristic radiological presentation together with the cytomorphologic features previously mentioned led to the diagnosis of giant cell tumor in our five cases studied, with histopathologic confirmation in four of them. All the five cases studied showed no atypia or suspicion of malignancy.
The differential diagnosis between osteomyelitis and neoplasm may be difficult clinically and radiologically; therefore, the results of bacterial culture and the cytologic presence of mostly inflammatory cells help to establish the diagnosis of osteomyelitis (Nnodu et al., 2006). Inflammatory bony lesions in the current study included two cases of acute and three cases of chronic osteomyelitis.
The rest of our cytologically diagnosed ‘benign lesions’ included four cases of Langerhans cell histiocytosis, three of lipomatous lesion, three of hemangioma, and three of aneurysmal bone cyst, with frequencies of 17.4 and 13% (for the latter three tumors), respectively.
The more problematic group is the group of inadequate FNAs. There are no established adequacy criteria for bone cytology. Thus, the number of inadequate cases varies between cytopathologist, by institution, and by study. One study defined adequacy in bone FNA biopsies as the presence of at least five clusters of 10 unobscured cells on the majority of slides (Kreicbergs et al., 1996). Acceptance of FNAC of bone as a diagnostic technique has been impeded by the inability to obtain adequate smears. However, the rate of inadequate aspirates, ranging from 0% (Layfield et al., 1987) to 33% (Dollahite et al., 1989), compares favorably with the rate published for open or cutting core needle biopsies (Springfield and Rosenberg, 1996; Gogna et al., 2008). The presence of a cytopathologist during the FNAC sampling procedure should reduce the percentage of inadequate aspirates. Thus, immediately after an unsuccessful FNAC, the radiologist could proceed to obtain a core biopsy (Ayala et al., 1995). In this study, an experienced cytopathologist usually attended the procedure of FNAC, which can partially explain our low rate (4.7%) of initial insufficient aspirates. The variability in reported inadequacy rates also depends on the number of cases reviewed in the studies. In fact, the highest reported inadequacy rate was reported in a study with no onsite evaluation, where 97 of 314 cases (31%) were deemed inadequate (Jorda et al., 2000). Thus, our study and other studies (Bommer et al., 1997; Jorda et al., 2000; Nnodu et al., 2006; Layfield, 2009) suggest that onsite evaluation not only reduces the inadequacy rate but also significantly enhances the diagnostic value of FNA in bone cases.
We conclude that when sampling is adequate and the clinicoradiologic findings are available, FNAC of bone is a highly accurate diagnostic technique. Inflammatory conditions, benign, nonfibrotic bone lesions as well as primary and metastatic malignant tumors can be diagnosed correctly. Considering the overall advantages and cost analysis, FNAC may be suggested as the initial method of choice for the evaluation of bony lesions in most clinical settings, especially in resource-challenged countries.
Conflicts of interest
There are no conflicts of interest.
Ayala AG, Ro JY, Fanning CV, Flores JP, Yasko AW.Core needle biopsy and fine-needle aspiration in the diagnosis of bone and soft-tissue lesions.Hematol Oncol Clin North Am1995;9:633–651.
Bommer KK, Ramzy I, Mody D.Fine-needle aspiration biopsy in the diagnosis and management of bone lesions: A study of 450 cases.Cancer1997;81:148–156.
Chao S, Mullins ME, Gallagher L, Slanetz PJ.Primary non-Hodgkin’s lymphoma of the femur.Am J Roentgenol2001;176:1160.
Chow W, Haglund K, Randall RLPazdur R, Wagman LD, Camphausen KA, Hoskins WJ.Bone Sarcomas.Cancer management, a multidisciplinary approach2011:13 ed..USA:UBM Medica.
Dollahite HA, Tatum L, Moinuddin SM, Carnesale PG.Aspiration biopsy of primary neoplasms of bone.J Bone Joint Surg Am1989;71:1166–1169.
Eyesan SU, Idowu OK, Obalum DC, Nnodu OE, Abdulkareem FB.Surgical consideration for benign bone tumors.Niger J Clin Pract2011;14:146–150.
Eyre R, Feltbower RG, Mubwandarikwa E, Jenkinson HC, Parkes S, Birch JM, et al..Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981–2002.Br J Cancer2009;100:188–193.
Flemming DJ, Murphey MD.Enchondroma and chondrosarcoma.Semin Musculoskelet Radiol2000;4:59–71.
Gogna A, Peh WCG, Munk PL.Image-guided musculoskeletal biopsy.Radiol Clin North Am2008;46:455–473.
Handa U, Bal A, Mohan H, Bhardwaj S.Fine needle aspiration cytology in the diagnosis of bone lesions.Cytopathology2005;16:59–64.
James LP, Frable WJ.Fine needle aspiration of bone lesions.Acta Cytol1983;27:559.
Jorda M, Rey L, Hanly A, Ganjei-Azar P.Fine-needle aspiration cytology of bone: accuracy and pitfalls of cytodiagnosis.Cancer2000;90:47–54.
Kabukçuoglu F, Kabukçuoglu Y, Kuzgun U, Evren I.Fine needle aspiration of malignant bone lesions.Acta Cytol1998;42:875–882.
Kreicbergs A, Bauer HCF, Brosjö O, Lindholm J, Skoog L, Söderlund V.Cytological diagnosis of bone tumours.J Bone Joint Surg Br1996;78:258–263.
Layfield LJ, Glasgow BJ, Anders KH, Mirra JM.Fine needle aspiration cytology of primary bone lesions.Acta Cytol1987;31:177–184.
Layfield LJ.Cytologic diagnosis of osseous lesions: a review with emphasis on the diagnosis of primary neoplasms of bone.Diagn Cytopathol2009;37:299–310.
Mehrotra R, Singh M, Singh PA, Mannan R, Ojha VK, Singh P.Should fine needle aspiration biopsy be the first pathological investigation in the diagnosis of a bone lesion? An algorithmic approach with review of literature.CytoJournal2007;4:9.
Moatasim A, Haque AU.Spectrum of bone lesions diagnosed on fine needle aspiration cytology.Int J Pathol2005;3:57–64.
Nagira K, Yamamoto T, Akisue T, Marui T, Hitora T, Nakatani T, et al..Reliability of fine-needle aspiration biopsy in the initial diagnosis of soft-tissue lesions.Diagn Cytopathol2002;27:354–361.
Nnodu OE, Giwa SO, Eyesan SU, Abdulkareem FB.Fine needle aspiration cytology of bone tumours – the experience from the National Orthopaedic and Lagos University Teaching Hospitals, Lagos, Nigeria.CytoJournal2006;3:16.
Purohit S, Pardiwala D.Imaging of giant cell tumor of bone.Indian J Orthop2007;41:91–96.
Shah SH, Muzaffar S, Soomro IN, Pervez S, Hasan SH.Clinico-morphological pattern and frequency of bone cancer.J Pak Med Assoc1999;49:110–112.
Söderlund V, Skoog L, Kreicbergs A.Combined radiology and cytology in the diagnosis of bone lesions: a retrospective study of 370 cases.Acta Orthop Scand2004;75:492–499.
Springfield DS, Rosenberg A.Biopsy: complicated and risky.J Bone Joint Surg Am1996;78:639–643.
Tarkkanen M, Larramendy ML, Böhling T, Serra M, Hattinger CM, Kivioja A, et al..Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.Eur J Cancer2006;42:1172–1180.
Wahane RN, Lele VR, Bobhate SK.Fine needle aspiration cytology of bone tumors.Acta Cytol2007;51:711–720.
©2013Egyptian Journal of Pathology
Walaas L, Kindblom L-G.Fine-needle aspiration biopsy in the preoperative diagnosis of chordoma: a study of 17 cases with application of electron microscopic, histochemical, and immunocytochemical examination.Hum Pathol1991;22:22–28.